US Stock MarketDetailed Quotes

KNX Knight-Swift Transportation

Watchlist
  • 50.440
  • +1.460+2.98%
Close Feb 28 16:00 ET
  • 50.210
  • -0.230-0.46%
Post 20:01 ET
8.17BMarket Cap69.10P/E (TTM)

Knight-Swift Transportation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Knight-Swift Transportation Q4 2024 Earnings Date

Currency：USDJan 22, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.88B
1.86B
-17.95M
Miss Est.
-2.57%
-3.50%
-0.95%
EPS
0.27
0.43
+0.16
Beat Est.
+492.42%
+714.29%
+56.76%
Analyst Rating
Buy

Mar 1, 2025

Knight-Swift Transportation Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.925B--
--2025/Q1-- / 1.829B--
Jan 22, 20252024/Q41.864B / 1.882B--
Oct 23, 20242024/Q31.877B / 1.911B--
Jul 24, 20242024/Q21.847B / 1.834B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.925B--
--2025/Q1-- / 1.829B--
Jan 22, 20252024/Q41.864B / 1.882B--
Oct 23, 20242024/Q31.877B / 1.911B--
Jul 24, 20242024/Q21.847B / 1.834B--

Unlock Free Earnings Estimates

Knight-Swift Transportation Earnings Reports

  • Knight-Swift Transportation | 10-K: FY2024 Annual Report

    Feb 20 12:11 ET

  • Knight-Swift Transportation | 10-Q: Q3 2024 Earnings Report

    Oct 30, 2024 13:22 ET

  • Knight-Swift Transportation | 10-Q: Q2 2024 Earnings Report

    Jul 31, 2024 13:06 ET

  • Knight-Swift Transportation | 10-Q: Q1 2024 Earnings Report

    May 1, 2024 13:17 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 1, 2025

    Buy

    • Buy

      76.92%

    • Hold

      15.39%

    • Sell

      7.69%

    Price Target

    No Data